#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14390	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2129	668.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1423	1423	C	820	C	770	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25860	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3507	732.1	0	.	n	.	0	A20C	SNP	20	20	A	255	255	C	471	C,A	433,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25860	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3507	732.1	0	.	n	.	0	T695C	SNP	695	695	T	930	930	C	830	C	766	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25860	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3507	732.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	1873	1873	G	887	G	818	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25860	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3507	732.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2206	2206	C	786	C	717	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25860	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3507	732.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2280	2280	A	829	A	760	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25860	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3507	732.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2832	2832	C	848	C	794	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	68	blaTEM	861	861	99.77	blaTEM.l6.c30.ctg.1	916	6.3	0	.	p	.	0	M180T	NONSYN	538	540	ATG	558	560	ACG	4;4;4	A;C;G	4;4;4	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1876	folP	855	855	100.0	folP.l15.c17.ctg.1	1540	120.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1007	1009	AGC	211;211;211	A;G;C	195;194;196	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5054	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3331	151.0	1	SNP	p	S91F	1	.	.	271	273	TTC	515	517	TTC	188;188;194	T;T;C	174;176;176	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5054	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3331	151.0	1	SNP	p	D95G	1	.	.	283	285	GGC	527	529	GGC	202;201;197	G;G;C	185;182;180	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5054	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3331	151.0	1	SNP	p	G95N	0	.	.	283	285	GGC	527	529	GGC	202;201;197	G;G;C	185;182;180	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1556	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1195	129.0	0	.	p	.	0	F184L	NONSYN	550	552	TTC	815	817	TTG	175;173;173	T;T;G	165;163;163	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1556	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1195	129.0	1	SNP	p	G45D	0	.	.	133	135	GGC	398	400	GGC	200;201;201	G;G;C	187;189;189	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	832	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	933	88.3	0	.	n	.	0	A197.	DEL	197	197	A	578	578	A	211	A	189	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4838	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2880	166.8	1	SNP	p	D86N	0	.	.	256	258	GAC	536	538	GAC	188;185;186	G;A,C;C,T	168;163,1;166,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4838	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2880	166.8	1	SNP	p	S87R	1	.	.	259	261	CGT	539	541	CGT	187;188;190	C;G,A;T	170;170,1;174	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4838	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2880	166.8	1	SNP	p	R87W	0	.	.	259	261	CGT	539	541	CGT	187;188;190	C;G,A;T	170;170,1;174	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4838	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2880	166.8	1	SNP	p	R87I	0	.	.	259	261	CGT	539	541	CGT	187;188;190	C;G,A;T	170;170,1;174	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4838	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2880	166.8	1	SNP	p	S88P	0	.	.	262	264	TCC	542	544	TCC	191;193;194	T;C;C	177;177;179	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4028	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2564	155.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1535	1537	GGC	195;196;197	G;G;C	174;174;172	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2404	151.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1285	1287	GCA	215;212;214	G;C;A	195;193;197	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2404	151.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1288	1290	ATC	210;211;214	A;T;C	196;192;194	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2404	151.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1300	1302	GTG	208;208;208	G;T;G	189;188;191	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2404	151.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1300	1302	GTG	208;208;208	G;T;G	189;188;191	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2404	151.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1804	1806	ACC	198;198;200	A;C;C	169;179;178	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2404	151.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1858	1860	GCG	165;162;164	G;C;G	139;127;135	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2404	151.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1858	1860	GCG	165;162;164	G;C;G	139;127;135	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2404	151.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1981	1983	AGC	142;140;141	A;G;C	131;129;128	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2404	151.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1990	1992	GGC	136;134;131	G;G;C	124;122;119	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2404	151.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2008	2010	CCG	113;113;115	C,G;C;G,A	83,1;85;86,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5390	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3175	168.4	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1646	1648	CTG	202;200;201	C;T;G	181;177;180	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2124	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1671	125.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	547	547	C	161	C	151	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1406	194.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	331	333	GAA	233;233;233	G;A;A	213;213;213	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1406	194.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	742	744	TCA	250;249;250	T;C;A	232;231;233	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1406	194.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	871	873	GTC	231;231;230	G;T,C;C,A	217;216,1;217,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1406	194.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	883	885	TCT	220;218;221	T;C;T	207;207;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1406	194.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1201	1203	GCA	220;225;224	G;C,A;A	197;201,1;199	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1406	194.4	1	SNP	p	G120K	1	.	.	358	360	AAG	577	579	AAG	227;228;228	A;A;G	211;213;212	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1406	194.4	1	SNP	p	A121D	1	.	.	361	363	GAC	580	582	GAC	234;231;233	G;A;C	214;212;214	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1406	194.4	1	SNP	p	D121N	0	.	.	361	363	GAC	580	582	GAC	234;231;233	G;A;C	214;212;214	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	116	92.24	porB3.l15.c17.ctg.1	363	34.5	0	.	p	.	0	M18T	NONSYN	52	54	ATG	233	235	ACG	71;69;64	A;C;G	58;58;54	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	116	92.24	porB3.l15.c17.ctg.1	363	34.5	0	.	p	.	0	T29A	NONSYN	85	87	ACC	266	268	GCC	52;50;50	G;C;C	44;41;41	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	116	92.24	porB3.l15.c17.ctg.1	363	34.5	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	275	277	CAA	35;33;32	C;A;A	31;30;30	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	326	porB3	990	116	92.24	porB3.l15.c17.ctg.1	363	34.5	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	281	283	TAC	23;23;20	T;A;C	21;20;19	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10612	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4871	216.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1036	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1069	96.0	1	SNP	p	V57M	1	.	.	169	171	ATG	522	524	ATG	216;220;219	A;T;G	205;209;208	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	20	tetM	1920	349	100.0	tetM.l15.c4.ctg.1	349	2.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	20	tetM	1920	286	99.65	tetM.l15.c4.ctg.2	286	1.7	0	.	p	.	0	L112trunc	TRUNC	334	334	T	21	21	T	1	T	1	.	Tetracycline resistance
